About GiveVision
About GiveVision
One in three people will lose their sight by the age of 65. For many of us, it is not a question of if, but a matter of how soon.

We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.

Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.

Our mission is to create a world where everyone can see.
One in three people will lose their sight by the age of 65. For many of us, it is not a question of if, but a matter of how soon.

We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.

Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.

Our mission is to create a world where everyone can see.
Leadership Team
Kip Kokinakis
COO
With 45 years of experience of international operations and managing companies in Europe and Asia. Over the last 20 years, Kip served as a CEO or COO running wearable technology companies, responsible for the design, production and commercialisation of nine different Head-Mounted Displays (HMDs).

As a CEO of Myvu (the HMD that inspired Google Glass), Kip developed and shipped three products that were eventually commercialised by Best Buy in the US.

Later, as a COO of WaveOptics (pioneering HMD company in Oxford, UK) Kip helped get the company off the ground, securing its first big commercial deal and major investment round. Finally, Kip served as President of the eMagin corp. HMD Division and pioneered night vision goggles for consumer applications.
Elodie Draperi
Co-founder & CEO
Expérience en entrepreneuriat social et en design thinking en tant que MakeSense Leader au Royaume-Uni. Récompensé de meilleure initiative de mécénat d’entreprise entre les secteurs public et privé lorsqu’elle travaillait au ministère de l’Écologie

At GiveVision, Elodie has built a pipeline of 3,000 patients, designed & validated Product-market-Fit developed a customer conversion funnel, as well as led on a number of key corporate partnerships and relationships with the clinical community and world-leading research institutions, including Moorfield’s Eye Hospital.

She also conducted prototype evaluation interviews with over 1000 patients and led the development of our "one-touch" user interface, which enabled patients as old as 96, with almost no sight, to learn and use the SightPlus device independently within minutes!
Stan Karpenko
Co-founder & CTO
Stan co-founded GiveVision in 2014, using the proceeds from selling his previous venture (YieldPartner.com) and developed the company until it was in a position to raise almost $2 million of non-dilutive funding from innovation agencies and government research grants.

In his role as CEO, Stan has led product development as well as the R&D of all GiveVision’s underlying technologies. He has built and led the cross-disciplinary team with niche expertise in AR, wearable hardware development, camera technologies, optical engineering, industrial design and manufacturing.

George Henry Hines
VP of Hardware Engineering
George has and extensive experience in both product development and operational management, with significant emphasis in consumer and wireless products. Has a proven track record of engineering and manufacturing consumer electronic devices from concept - to - scale.

Over the last 15 years, George has worked on some of his most complex breakthrough consumer hardware products including the worlds thinnest laptop from DELL, first dual screen smartphone, IP68 intrinsically safe smartphones and AR / Head Mounted Display devices.

George’s key strengths are: his rare expertise of combining electronic engineering, optical design and industrial design to manufacture wearable AR devices, as well as his experience of working with new materials and manufacturing processes to design consumer electronic products.
Piotr Imielski
Co-founder, Head of Software Engineering
Key software engineer behind all of the GiveVision’s software assets. Has designed and implemented our proprietary computer vision processing algorithms that allowed for low-power image processing, unrivalled for its speed and efficiency.

Over his 30-year career in software, Piotr has worked as a Senior Software Engineer on complex government and corporate projects and has experience of developing software products across large and micro teams. C++, Java, OpenGL, php, JAVAScript; Android, Linux, Kernel and cloud database systems.
Peter Jonhston
Head of Business Development
Peter’s career started over thirty years ago with (what is now) AstraZeneca, 8 years where he learnt the essentials of how multinational pharma companies operate.

From AstraZeneca he moved to Adis International in medical communications and publishing. He then spent many years working for a variety of mainly US-based tech companies selling products & services into the pharma sector, helping them grow their EU revenues and businesses.

In 2015 he moved to Merck KGaA as Director, New Channels eHealth, directing the commercialisation of an innovative digital health platform.
Tariq Aslam
Chief Medical Officer
Consultant Ophthalmologist at Manchester Royal Eye Hospital specialising in medical retina and Professor at the University of Manchester.

His current research explores many clinical interests in retina including psychological aspects and the potential for computerised and technological enhancement of patient care including novel device development. He has over 100 peer-reviewed publications and several patents.

Tariq is an investigator in multiple industries and investigator-led clinical studies. His research has led to a spin-out medical technology company with awards for social impact.
Prof Marc Robert Clement
Board Chairman, interim Chief Science Officer
Marc is a renowned academic, inventor and entrepreneur in the field of Life Science and Medical Technology. Vice Chancellor and Chief Executive of the University of Wales (2007 - 2012), Marc is the author and inventor of over 50 patents and has founded many medical technology companies. He has served on the Boards of numerous UK companies and several NASDAQ companies

Marc has been directly responsible for raising in excess of £200m investment in the public and private sector endeavours. He is widely recognised as the architect of the £1.3bn Swansea Bay City Region Deal signed by the Prime Minister in 2018.

PhD in Laser Technology, Marc is a chartered engineer, chartered physicist, Fellow of the Institute of Physics and Fellow of the Institute of Engineering and Technology. He is also a founding Fellow of the Learned Society of Wales.

He has now retired from academic life and is pursuing a career as an entrepreneur and innovator in life science.
Dr Soulaiman Itani
Board Director - Product Development
Soulaiman Itani is a founder of Atheer - a pioneering company in AR, that created the world’s first mobile holographic interaction smart glasses. Atheer, created the first mobile natural interaction AR glasses controlled by gestures, voice, and motion.

Under Soulaiman’s leadership, Atheer raised more than $40M in funding from Silicon Valley and grew to a market leader in AR, generating multi-million revenues.

Thanks to Soulaiman’s vision and aggressive IP strategy, Atheer today, is at the centre of the AR SW for the enterprise. It’s patented SW suite is pre-installed on many market leading OEM AR hardware and is a default operating system for B2B AR solutions.

MIT/Berkeley trained with a Ph.D. in Electrical Engineering and Computer Science, holding more than 40 patents in AR, VR, vision ergonomics, Computer Vision and Machine Learning, and AI

Soulaiman brings to our board his experience and proven ability to create cutting edge technology and IP, design and implement new business models, develop strategic partnerships, and negotiate and sign multi-million dollar deals with F100 companies.

Alex Shlyankevich
Board Director - Clinical & Commercial
Background in brand and generic pharmaceutical, biotech, drug delivery, medical devices, service, contract pharma, and start-up companies with hands-on technical and managerial leadership experience in CMC sciences and operations throughout drug life cycle.

Contributor to multiple successful drug development programs, regulatory filings and product launches with thorough understanding of compliance, business and budgetary aspects of CMC operations. Hands-on experience in dealing with the FDA and BfArM during submission, approval and commercial stages.

Track record of solving CMC-related problems in product development using multidisciplinary approach. Achievements in cross-functional and international facilitation, program leadership, collaboration management, business and capabilities presentation, and start-up organization growth. Extensive practical knowledge of outsourcing as a client and service provider.
Leadership Team
Kip Kokinakis
COO
Elodie Draperi
Co-founder & CEO
Stan Karpenko
Co-founder & CTO
George Henry Hines
VP of Hardware Engineering
Piotr Imielski
Co-founder, Head of Software Engineering
Peter Jonhston
Head of Business Development
Tariq Aslam
Chief Medical Officer
Prof Marc Robert Clement
Board Chairman, interim Chief Science Officer
Dr Soulaiman Itani
Board Director - Product Development
Alex Shlyankevich
Board Director - Clinical & Commercial
Advisors

Antonin (Tony) de Fougerolles
CEO of Evox, CSO at Ablynx & Moderna
Currently CEO of Evox Therapeutics, Tony has over 20 years of biotech R&D experience in creating transformative treatments for patients. He has played a key role in developing and successfully advancing 3 new drug modalities towards the market and in helping build several multi-billion dollar companies from start-up stage.
Dr Mike Short CBE
Chief Scientific Adviser, Department for International Trade (DIT)
Mike leads the science and engineering profession in the department and ensures its policy is informed by the best science, engineering and technical advice. He advises on the technical aspects of future trade deals as DIT looks to create new arrangements following Brexit, and works with the UK’s research, development and academic communities to boost scientific and engineering exports.

Mike has over 40 years’ experience in electronics and telecommunications and served as Vice President of Telefonica, the parent company of the O2 mobile phone network, for 17 years. In this post, he managed the launch of 2G (GSM) and 3G mobile technologies in the UK, and led research and development for Telefonica Europe.

Former Chairman of the Global GSM Association, the UK Mobile Data Association, and president of the Institution of Engineering and Technology.
Dr Nevan Clancy Hanumara
Research Scientist, Massachusetts Institute of Technology (MIT)
Dr. Hanumara is a Research Scientist in MIT Mechanical Engineering’s Precision Engineering Research Group where he leads the group’s healthcare design effort

He co-instruct MIT’s Medical Device Design course, which fosters clinical-engineering and focuses on human-centered design, with application in clinical settings.

Nevan holds a PhD and MS in Mechanical engineering from MIT and a BS in Mechanical Engineering and BA in French from the University of Rhode Island’s International Engineering Program.
Dr Hamish Graham
London manager for the Pfizer Healthcare Hub and a practicing surgeon
Hamish runs The Pfizer Healthcare hubs - are a global network, designed to help innovators transform the lives of more patients and healthcare practitioners.

As Pfizer Healthcare Hub London lead, Hamish’s role is to connects innovators in digital healthcare with patients, healthcare practitioners, healthcare leaders and industry experts from Pfizer to VCs.


The team at HMD-Tech
A French enterprise, based in Lille, is experienced in the fields of virtual reality, mobile app development, product design and manufacturing.
Advisors

Antonin (Tony) de Fougerolles
CEO of Evox, CSO at Ablynx & Moderna
Dr Mike Short CBE
Chief Scientific Adviser, Department for International Trade (DIT)
Dr Nevan Clancy Hanumara
Research Scientist, Massachusetts Institute of Technology (MIT)
Dr Hamish Graham
London manager for the Pfizer Healthcare Hub and a practicing surgeon
The team at HMD-Tech
Investing in vision:
Meet the organisations who funded the development of this technology:
GiveVision CAREERS
Your talent here.
At GiveVision we are creating a platform for enhancing human vision and achievement. Does your background include product design, user experience, applied physics, hardware, software, optics, photonics, electronics, chemistry, biology, or vision science? If so, we should talk.
Our Supporters: